As of November 6, 2026, Intuitive Surgical Inc has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 28, 2026 to November 2, 2026, naming 1 appointment. The latest filing names Aaron Martin, appointed (Form 8-K, November 2, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Intuitive Surgical Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Intuitive Surgical Inc reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-28 to 2026-11-02. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Intuitive Surgical Inc files it.
Also on the record for Intuitive Surgical Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 7.49% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
Selling to them or working with them? See who runs Intuitive Surgical Inc now and the warning signs.
Free to see. No signup.
Keep reading
More on Intuitive Surgical Inc and the records around it.
Companies that share a holder
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Intuitive Surgical Inc
Get an email when Intuitive Surgical Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Intuitive Surgical Inc?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Intuitive Surgical Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Intuitive Surgical Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-11-02 | In | 2027-01-01 | 8-K, 2026-11-02 | ||
| 2026-05-28 | Reported | not named in the filing | 8-K, 2026-05-28 |
New leaders reset buying decisions — get the Full Report on Intuitive Surgical Inc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Intuitive Surgical Inc, with the record behind each one.
Find candidates like senior executive at Intuitive Surgical IncEvery change, in the filing's words
Appointed: Aaron Martin, effective 2027-01-01
On October 29, 2026, the Board of Directors (the "Board") of Intuitive Surgical, Inc. (the "Company") approved an increase in the size of the Board from ten to eleven members and appointed Aaron Martin to fill the resulting vacancy, effective as of January 1, 2027.
- Mr. Martin will not be appointed to any committees as of the effective date.
- The Board has determined that Mr. Martin is an independent director under applicable rules of the Nasdaq Stock Market ("Nasdaq") and the U.S. Securities and Exchange Commission.
- Pursuant to the Company's standard compensation program for its non-employee directors, Mr. Martin will receive an annual cash retainer of $70,000 for service as a member of the Board, which amount will be prorated for the portion of the fiscal year remaining following the effective date of his appointment.
- Mr. Martin will receive, pursuant to the Company's Amended and Restated 2010 Incentive Award Plan, an initial grant of restricted stock units ("RSUs") with a value of $93,333, which is a prorated amount based on the number of months remaining between the effective date of his appointment and the expected date of the next annual grant (the "Target RSU Value").
- The number of RSUs granted will be determined by dividing the Target RSU Value by the 30 trading-day average closing price of the Company's common stock, as reported by Nasdaq, through the last trading day of the month prior to the grant date.
Reported
Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company's Chief Commercial and Marketing Officer.
- Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the "Company") and begin serving as Senior Vice President of Global Business Operations of the Company.
Tools for this story
Each opens in a new tab, filled in for Intuitive Surgical Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.